Medicinal Cannabis and Liver Enzymes in Advanced Cancer: Safety Evidence from RCTs
Clinical trials show that medicinal cannabis, including CBD and THC/CBD combinations, does not cause clinically significant liver enzyme elevations in advanced cancer patients. This evidence supports its safety for short-term use, addressing concerns…
Therapeutic potential and pharmacological mechanisms of cannabinoids in alleviating chemotherapy-induced organ toxicity and adverse effects.
A comprehensive review examines how cannabinoids chemotherapy organ protection mechanisms could address treatment-limiting toxicities. While theoretical evidence suggests promise through anti-inflammatory and antioxidant pathways, clinical validation…
Understanding Cannabis Use for Nausea and Anxiety During Cancer Treatment
Cannabis nausea anxiety cancer treatment is an emerging area of clinical interest. This page reviews developments relevant to cannabis medicine for symptom management. Clinicians should monitor evidence carefully for patient care implications.
Exploring Cannabis Use in Cancer Treatment: Patient Safety & Communication
Cannabis use in cancer treatment raises important patient safety concerns and clinical communication needs. Self-medication with cannabis for cancer requires careful oversight to avoid delays in proven therapies. Oncology teams should address cannabis…
Unsung Cannabis Crusader: The Untold Story of Medical Marijuana & Cancer
Cannabis pharmacology cancer research reveals how cannabinoids interact with cancer biology and symptom management. Raphael Mechoulam's pioneering studies laid the groundwork for clinical interest in medical marijuana for cancer patients. Understanding…
CBD & Cancer: The COM-Scale Scientific Evidence Project by Krisztian Smith – Indiegogo
Crowdfunded cannabis research projects focusing on CBD and cancer are gaining attention but often lack rigorous scientific oversight. This article reviews the COM-Scale Scientific Evidence Project by Krisztian Smith. Clinicians should carefully evaluate…